South Africa rolls out six-monthly HIV prevention jab lenacapavir

A South African news outlet publishes a practical guide for patients seeking lenacapavir, a new six-monthly HIV prevention injection, detailing the clinic process from testing to administration. The piece signals growing availability of the drug in the country, though it does not specify national rollout scale or pricing. This matters as lenacapavir could significantly improve HIV prevention adherence in high-burden regions.